Kimia Biosciences Ltd. (KIMIABL.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+58.3%

₹47.48

vs ₹30.00 price

Levered DCF

₹23.19

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	14.36×	20.51×	-47.38×	-19.93×	-50.6×	36.55×	119.61×	14.95×
P/B	6.02×	19.76×	758.43×	34.18×	12.54×	10.13×	12.33×	9.43×
P/S	0.93×	1.66×	2.41×	1.46×	1.5×	1.41×	1.54×	0.61×
EV / EBITDA	9.9×	11.22×	433.94×	-49.71×	148.2×	21.64×	37.33×	15.09×
Gross margin	24.6%	20.0%	3.3%	1.7%	3.9%	8.9%	8.7%	9.9%
Operating margin	9.0%	13.8%	-4.1%	-5.6%	-2.0%	4.9%	3.8%	5.0%
Net margin	6.5%	8.1%	-5.1%	-7.3%	-3.0%	3.8%	1.3%	4.1%
Current ratio	1.04×	0.92×	0.88×	1.08×	1.18×	1.38×	1.58×	1.56×
Debt / equity	1.96×	3.95×	132.05×	9.69×	3.06×	2.68×	2.84×	5.01×
Interest coverage	2.95×	4.06×	-0.93×	-1.68×	-0.67×	1.73×	1.48×	2.2×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	41.9%	96.5%	-1603.8%	-171.2%	-24.9%	27.7%	10.3%	63.1%
Return on invested capital	16.9%	21.5%	-5.9%	-7.8%	-2.8%	8.2%	7.2%	11.0%
Return on assets	7.2%	8.5%	-5.3%	-7.6%	-3.3%	4.8%	1.6%	5.8%
Free cash flow yield	-1.8%	5.5%	3.8%	-6.6%	0.6%	-5.4%	-5.9%	-10.5%
Earnings yield	7.0%	4.9%	-2.1%	-5.0%	-2.0%	2.7%	0.8%	6.7%
Enterprise value	₹1.4B	₹2.4B	₹2.9B	₹2.4B	₹2.3B	₹2.3B	₹2B	₹869.5M
Net debt / EBITDA	2.42×	1.86×	64.16×	-10.9×	28.77×	4.41×	6.88×	5.09×
Cash conversion cycle (days)	28	60	68	99	91	99	105	107